| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addictovigilance contribution during COVID-19 epidemic and lockdown in France
|
Lapeyre-Mestre, Maryse
|
|
|
75 |
4 |
p. 343-354
|
artikel
|
| 2 |
Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data
|
Grandvuillemin, Aurélie
|
|
|
75 |
4 |
p. 385-387
|
artikel
|
| 3 |
Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review
|
Grange, Lucile
|
|
|
75 |
4 |
p. 335-342
|
artikel
|
| 4 |
Chloroquine and hydroxychloroquine during pregnancy: What do we know?
|
Lacroix, Isabelle
|
|
|
75 |
4 |
p. 384-385
|
artikel
|
| 5 |
Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence
|
Roustit, M.
|
|
|
75 |
4 |
p. 363-370
|
artikel
|
| 6 |
Diabetes and COVID-19
|
Bouhanick, Béatrice
|
|
|
75 |
4 |
p. 327-333
|
artikel
|
| 7 |
Drugs acting on renin angiotensin system and use in ill patients with COVID-19
|
Alexandre, Joachim
|
|
|
75 |
4 |
p. 319-325
|
artikel
|
| 8 |
Editorial board
|
|
|
|
75 |
4 |
p. i
|
artikel
|
| 9 |
Is the drug a scientific, social or political object?
|
Bordet, Régis
|
|
|
75 |
4 |
p. 389-391
|
artikel
|
| 10 |
Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection
|
Micallef, Joëlle
|
|
|
75 |
4 |
p. 355-362
|
artikel
|
| 11 |
NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection
|
Cumhur Cure, Medine
|
|
|
75 |
4 |
p. 387-388
|
artikel
|
| 12 |
“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers
|
Gérard, Alexandre
|
|
|
75 |
4 |
p. 371-379
|
artikel
|
| 13 |
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France
|
Montastruc, François
|
|
|
75 |
4 |
p. 381-384
|
artikel
|
| 14 |
Ultrafast response of the French Society of Pharmacology and Therapeutics to the COVID-19 pandemic
|
Cracowski, Jean-Luc
|
|
|
75 |
4 |
p. 317-318
|
artikel
|
Tijdschrift beschrijving